The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis
Open accessAbstract
Background In patients with isolated syndromes that are clinically suggestive of multiple sclerosis, such as optic neuritis or brain-stem or spinal cord syndromes, the presence of lesions as determined by T2-weighted magnetic resonance imaging (MRI) of the brain increases the likelihood that multiple sclerosis will develop. We sought to determine the relation between early lesion volume, changes in volume, and long-term disability. Methods Seventy-one patients in a serial MRI study of patients with isolated syndromes were reassessed after a mean of 14.1 years. Disability was measured with the use of Kurtzke's Expanded Disability Status Scale (EDSS; possible range, 0 to 10, with a higher score indicating a greater degree of disability). Results Clinically definite multiple sclerosis developed in 44 of the 50 patients (88 percent) with abnormal results on MRI at presentation and in 4 of 21 patients (19 percent) with normal results on MRI. The median EDSS score at follow-up for those with multiple sclerosis was 3.25 (range, 0 to 10); 31 percent had an EDSS score of 6 or more (including three patients whose deaths were due to multiple sclerosis). The EDSS score at 14 years correlated moderately with lesion volume on MRI at 5 years (r=0.60) and with the increase in lesion volume over the first 5 years (r=0.61). Conclusions In patients who first present with isolated syndromes suggestive of multiple sclerosis, the increases in the volume of the lesions seen on magnetic resonance im…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional T2-weighted MRI (cMRI) largely fails to predict the degree of patients' disability.”
From Diffusion tensor imaging of post mortem multiple sclerosis brain (2007) · cites this paper as Brex et al., 2002
In the citing paper
“The inability of cMRI to reflect MS pathology in more detail may be one of the major reasons why the correlation between cMRI measures and disability is only modest (Kappos et al., 1999; Brex et al., 2002).”
From Diffusion tensor imaging of post mortem multiple sclerosis brain (2007) · cites this paper as Brex et al., 2002
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Practical Statistics for Medical Research.
Walter, S., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,666
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Self-citationTests for comparing elements of a correlation matrix
Steiger, J. H. (1980) · Psychological Bulletin · doi:10.1037/0033-2909.87.2.245 · Cited by 4,621
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Defining the clinical course of multiple sclerosis
LUBLIN, F. D., & Reingold, S. C. (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,762
Flagged first, then by citations
Research works printed but not linked: 2
- Molyneux PD, 1998, AJNR Am J Neuroradiol, 19, 1715
- Paty DW, 1993, Neurology, 43, 6627
Cited by
Sorted by citations
Items 701–800 of 858
Neurogenic Bladder for Multiple Sclerosis Patients
Stoffel, J. T. (2010) · Cited by 1
MAGNETIC RESONANCE IMAGING OF MULTIPLE SCLEROSIS
Naismith, R. T., & Cross, A. H. (2007) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293643.43858.9a · Cited by 1
MULTIPLE SCLEROSIS CLINICAL TRIAL DESIGN AND ANALYSIS
Burton, J., & O'Connor, P. W. (2004) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293632.77732.a8 · Cited by 1
Tourbah, A. (2010) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(10)52319-6 · Cited by 1
Clinical Use of OCT and MSON Mimics
Petzold, A., & Plant, G. T. (2015) · Springer eBooks · doi:10.1007/978-3-319-20970-8_5 · Cited by 1
Defer, G. L., Brochet, B., & Pelletier, J. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-70469-7.00002-2 · Cited by 1
Vališ, M., Vyšata, O., Sobíšek, L., Klímová, B., Andrýs, C., Vokurková, D., & Pavelek, Z. (2018) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0100 · Cited by 1
Llufriú, S., Agüera, E., Costa‐Frossard, L., Galán, V., Landete, L., Lourido, D., Meca-Lallana, J. E., Moral, E., Bravo-Rodríguez, F. A., Koren, L., et al. (2021) · Neurología · doi:10.1016/j.nrl.2021.01.012 · Cited by 1
Lee, M. S. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50285-x · Cited by 1
Narayan, R., Stüve, O., & Shah, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-62539-5.00046-1 · Cited by 3
Multiple Sclerosis: Symptom and Side Effect Management
(2006) · International Journal of MS Care · doi:10.7224/1537-2073-8.s1.4 · Cited by 1
Traitements de fond de la sclérose en plaques. État des lieux et perspectives
Magy, L. (2022) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2022.01.031 · Cited by 5
Uso clínico da testosterona e seus derivados químicos: uma revisão narrativa
Aragão, G. L. B., Resende, M. S. D. A. B., de Almeida, L. M. G. F., Santana, D. C., & Menezes, M. V. C. (2022) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e10608.2022 · Cited by 1
Neuritis óptica inflamatoria y esclerosis múltiple, ¿existe una relación?
Facultad de Medicina Humana "Dr. Manuel Velasco Suárez", C. I., & Galindo, A. T. (2025) · Revista Anales de Medicina Universitaria · doi:10.31644/amu.v03.n03.2025.a11 · Cited by 1
Chapter 19 Optic neuropathies and disorders of optic chiasma
Kaufman, D. I., & Eggenberger, E. (2005) · Handbook of clinical neurophysiology · doi:10.1016/s1567-4231(09)70216-3 · Cited by 1
Multiple Sklerose und andere autoimmune ZNS-Erkrankungen
Kroner, A., Kleinschnitz, C., Stadelmann, C., Raab, P., Stangel, M., Trebst, C., Voß, E. V., & Cordes, A.-L. (2011) · Springer eBooks · doi:10.1007/978-3-642-20477-7_1 · Cited by 1
Nielsen, J. F., Bech, E., Gadeberg, P., & Sinkjær, T. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00891.x · Cited by 1
MRI features of pediatric multiple sclerosis
Soares, B. P., Chabas, D., & Wintermark, M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974373.006 · Cited by 1
Surrogate Markers in Multiple Sclerosis
Rocca, M. A., Comı, G., & Filippi, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00015-5 · Cited by 2
Demir, S., Düzgun, E., Kafadar, C., Toğrol, E., Senol, G. M., & Çakır, A. (2017) · Medical Science and Discovery · doi:10.17546/msd.316511 · Cited by 1
Myelopathy: Retrospective Evaluation of Twenty-Eight Cases
Erdal, Y., Emre, U., Dartıcı, Z. S., Yalın, O. Ö., & Kılıçkesmez, N. Ö. (2017) · Turkish Journal Of Neurology · doi:10.4274/tnd.56689 · Cited by 1
Should Spinal MRI Be Routinely Performed in Patients With Clinically Isolated Optic Neuritis?
Meltzer, E. I., Frohman, E. M., Costello, F., Burton, J., & Frohman, T. C. (2018) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000685 · Cited by 2
Pathologie de la substance blanche
Dietemann, J.-L., Koob, M., Kremer, S., & Bogorin, A. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-75394-7.00016-3 · Cited by 1
Dayem, E. H. A., Hassan, T. H. G., Hameed, H. A. Q. A., & Botros, S. M. (2018) · The Egyptian Journal of Hospital Medicine · Cited by 1
Chen, J. J.-W., & Lee, M. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_42 · Cited by 1
Çınar, B. P., & Özakbaş, S. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2017.12667 · Cited by 1
Vermersch, P. (2004) · La Presse Médicale · doi:10.1016/s0755-4982(04)98519-3 · Cited by 1
Interferon Beta in Acute Optic Neuritis
Galetta, S. L., & Plant, G. T. (2006) · Neuro-Ophthalmology · doi:10.1080/01658100600651732 · Cited by 1
Casanova, B., Boscà, I. F., Parra, S., Pascual, A., & Coret, F. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1351xx · Cited by 1
DEFINING SUCCESS IN MULTIPLE SCLEROSIS: TREATMENT FAILURES AND NONRESPONDERS *
Greenberg, B. M., & Frohman, E. M. (2008) · Cited by 1
Lee, J. D. (2014) · cIRcle (University of British Columbia) · doi:10.14288/1.0165922 · Cited by 1
Multiple Sklerose und verwandte Krankheitsbilder
Rieckmann, P., & Mäurer, M. (2005) · Elsevier eBooks · doi:10.1016/b978-343723390-6.50044-9 · Cited by 1
Muraro, P. A., van Laar, J. M., Illei, G. G., & Pavletic, S. Z. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-10147-2.50023-0 · Cited by 1
Korkmaz, G., Lorenzi, R. M., Ravera, F., Alahmadi, A. A. S., Monteverdi, A., Kanber, B., Prados, F., D'Angelo, E. U., Palesi, F., Toosy, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.03.692031 · Cited by 1
Behandlung der multiplen Sklerose
Wiendl, H. (2003) · Steinkopff eBooks · doi:10.1007/978-3-642-57441-2_14 · Cited by 1
Sailer, M. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22083-8.00012-2
Self-citationParry, A. M., Clare, S., & Matthews, P. M. (2004) · Springer eBooks · doi:10.1007/978-88-470-2127-3_6
Genetic and Immunological Regulation of Neuroinflammation
Hedreul, M. T. (2012) · Figshare
Fatiga en esclerosis múltiple: aspectos clínicos, biológicos y radiológicos
Lara, N. T. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Acquired Demyelinating Disorders of the CNS in Children
Govender, R., Jo, M., & Wieselthaler, N. A. (2012) · InTech eBooks · doi:10.5772/23731
Interferon-Beta-1a subkutan in der Behandlung der Multiplen Sklerose
Fertl, E., & Krichmayr, M. (2008) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-008-0510-6
The contribution of brain reorganisation to recovery inpatients with optic neuritis
Jenkins, T. M. (2010) · UCL Discovery (University College London)
MRI in Multiple Sclerosis: From diagnosis to prognosis
Korteweg, T. (2011) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Moraal, B. (2010) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
MR Spectroscopy in Multiple Sclerosis - A New Piece of the Puzzle or Just a New Puzzle
Aboul‐Enein, F. (2012) · InTech eBooks · doi:10.5772/32340
Kolappan, M. (2013) · UCL Discovery (University College London)
Clinical and MRI features of primary progressive multiple sclerosis
Ingle, G. T. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Könnecke, H., & Schippling, S. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1766-8_4
Genetic and Immunological Mechanisms Regulating Neuroinflammation
Gillett, A. (2010) · Figshare
Multiple sclerosis lesions evolution in patients with clinically isolated syndrome
Crimi, A., Commowick, O., Ferré, J., Maarouf, A., Edan, G., & Barillot, C. (2013) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2006647
Çelebisoy, N., Kocaman, A. S., Güllüoğlu, H., Yüceyar, N., Gökçay, F., & Köse, T. (2011) · Neuro-Ophthalmology · doi:10.3109/01658107.2011.580888
Manifestaciones clínicas, historia natural, pronóstico y complicaciones de la esclerosis múltiple
Velasco, P. E. B., Quilez, M. R. B., Sánchez, A., & Merino, A. G. (2011) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(11)70058-0
Meeting Highlights on Psychiatric Treatment Perspectives in Neurology: The 3rd Annual Chair Summit
Ansted, C. J., Kennedy, R. S., Johnson, M. D., & Binford, S. H. (2011) · Health Outcomes Research in Medicine · doi:10.1016/j.ehrm.2011.07.008
Haas, L. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.2.147
New aspects regarding mechanisms of tissue damage in the course of autoimmune demyelination
Aktaş, O. (2005) · Signal Transduction · doi:10.1002/sita.200500059
Review: magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosis
Weinshenker, B. G. (2006) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.11.5.155
Gallì, P., Brochet, B., Jeannin, S., Olindo, S., Signaté, A., & Cabre, P. (2014) · Revue Neurologique · doi:10.1016/j.neurol.2014.01.290
Colledge, J., Quigley, S. F., & Liyanage, S. (2012) · BMJ · doi:10.1136/bmj.e2712
Protocolo diagnóstico del paciente con sospecha de enfermedad desmielinizante
Velasco, P. E. B., Quilez, M. R. B., Sánchez, A., & Merino, A. G. (2011) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(11)70062-2
Voiding Dysfunction in Multiple Sclerosis: Disease Review and Management
Togami, J. M. (2013) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-013-0213-8
Diagnosis and early prognosis of Multiple Sclerosis
Nielsen, J. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Heterogeneity in multiple sclerosis; a bio-marker approach
Zwemmer, J. (2011) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Spinal Cord Compression and Myelopathies
Schmalstieg, W. F., & Weinshenker, B. G. (2012) · Springer eBooks · doi:10.1007/978-0-387-88585-8_13
Magnetic Resonance Imaging Predictors for Disability in Multiple Sclerosis
Minneboo, A. (2008) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Neue therapeutische Konzepte bei der Multiplen Sklerose
Aktaş, O., & Hartung, H. (2010) · Nervenheilkunde · doi:10.1055/s-0038-1628764
Trastorno psicótico: Clave para el diagnóstico de esclerosis múltiple
Pascual, M. A., Roselló, A. P., Vilaplana-Pérez, A., & Monferrer, T. D. (2015) · Psiquiatría Biológica · doi:10.1016/j.psiq.2015.03.002
Brain–specific proteins in Multiple Sclerosis
Petzold, A. (2003) · UCL Discovery (University College London)
Malmeström, C. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)
CURRENT AND EMERGING TREATMENT STRATEGIES FOR MULTIPLE SCLEROSIS
Cohen, B. A. (2008)
Cheng, X., Cheng, Q., Miao, L., Guo, Z., Guan, Y., Liu, Z., Wang, X., Sun, X., Song, Y.-J., & Ding, X. (2013)
Sailer, M., Fazekas, F., Kappos, L., Rieckmann, P., Toyka, K. V., Wiendl, H., & Bendszus, M. (2008)
Self-citationPaty, D. W. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01188-6
Siddiqui, H. K., Ikram, K., Maqbool, S., Khan, T. Z., & Qazi, A. J. (2014) · Journal of Orofacial Research · doi:10.5005/jp-journals-10026-1153
Gene Expression and Variation in Multiple Sclerosis
Szvetko, A. L. (2009) · Griffith Research Online · doi:10.25904/1912/1563
Eraksoy, M., Mäurer, M. A., & Compston, A. (2014)
Rocca, M. A., Preziosa, P., Mesaroš, Š., Pagani, E., Dackovic, J. R., Stošić-Opinćal, T., Drulovic, J. S., & Filippi, M. (2016)
in Multiple s clerosis: An Imaging Marker of Disease 1
Walsh, A. J. L., Blevins, G., Lebel, R. M., Seres, P., Emery, D. J., & Wilman, A. H. (2014)
Weinstock‐Guttman, B., Grazioli, E., & Kolb, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00005-2
Chabas, D., & Waubant, E. L. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974373.004
Clinical Trials in Neuro-Ophthalmology
Tamhankar, M. A., & Balcer, L. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012648082-5/50009-5
The multiple sclerosis disease process as characterized by magnetic resonance imaging
Wolinsky, J. S. (2007) · CRC Press eBooks · doi:10.3109/9780203012055-5
Acute non compressive myelopathies
Cobo‐Calvo, Á. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Statistical Methods for Magnetic Resonance Image Analysis with Applications to Multiple Sclerosis.
Pomann, G. (2015) · NCSU Libraries Repository (North Carolina State University Libraries)
Clinically Isolated Syndrome (CIS) Presenting with Ataxia and
Kanjilal, S. D., & Ghosh, K. (2015)
Giannetti, P. (2015) · Spiral (Imperial College London) · doi:10.25560/34680
Multipl Sklerozisin İmmünpatogenezi Kısım 2: Hastalığın doğușu ve yükseliși
Atay, V., & Kurne, T. (2016) · Ankara Üniversitesi Tıp Fakültesi Mecmuası · doi:10.1501/tipfak_0000000923
Confounding Issues in the Diagnosis of Multiple Sclerosis: Lyme Disease Testing
Yu Bai, M., & Willis, M. S. (2003) · Laboratory Medicine · doi:10.1309/qxxw-aue9-tpyq-futj
Critères diagnostiques de la sclérose en plaques
Labauge, P. M. (2017) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2017.01.019
Clarner, T., & Beyer, C. (2011) · RWTH Publications (RWTH Aachen)
Ahmad, M. I. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47904-2.00046-5
Main clinical and neuroimaging predictors of disability progression in multiple sclerosis
Kobys, T. O. (2016) · Family Medicine · doi:10.30841/2307-5112.2(64).2016.102485
Current guidelines and standard treatments of RR-MS
Kinkel, R. P., & Miravalle, A. A. (2011) · doi:10.2217/ebo.11.111
Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review
Whiting, P. F., Harbord, R. M., Main, C., Deeks, J. J., Filippini, G., Egger, M., & Sterne, J. A. C. (2006) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2006.01254.x
Metadata
- Authors
- Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- Otto-von-Guericke-Universität Magdeburg (DE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-01-17
- Volume
- 346
- Issue
- 3
- Pages
- 158-164
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1966515383
- Cited by
- 861
- References
- 42
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 11 · 2023: 9 · 2022: 14 · 2021: 20 · 2020: 14 · 2019: 23 · 2018: 27 · 2017: 33 · 2016: 30 · 2015: 32 · 2014: 44 · 2013: 34 · 2012: 40
- FWCI
- 36.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- multiple sclerosis, long-term disability, Expanded Disability Status Scale, optic neuritis, spinal cord syndromes, T2-weighted MRI, disease-modifying therapy, disease progression
- MeSH terms
- Adolescent, Adult, Brain, Brain Diseases, Brain Stem, Disability Evaluation, Female, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Optic Neuritis, Spinal Cord Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review